Literature DB >> 24762990

[Establishment of methylation-specific quantitative PCR system for ID4 gene in acute leukemia cells and its specificity and sensitivity].

Yang Liu1, Hui-Yuan Kang2, Li-Li Wang3, Xue-Chun Lu1, Hong-Li Zhu4, Li Yu5.   

Abstract

DNA methylation of ID4 gene promoter occurred frequently in patients with acute leukemia and was found to be highly related to the tumor progression. Due to lack of the appropriate methylation detection methods, the relation between the quantification of ID4 methylation and the states of acute leukemia is still unclear. This study purposed to set up a methylation-specific quantitative PCR system for ID4 and investigate the specificity and sensitivity of this methylation detection. The plasmids combined with target gene as well as with internal reference were constructed, and the standard curves were set up by using above mentioned plasmids. The specificity of this detection system in cell lines was verified through techniques of MSP and quantitative MSP. The sensitivity of this detection system was verified by mixing methylation-positive and negative cell lines in varying proportions and through amplification of qualitative MSP. The results showed that the standard curves were establish successfully. The results of quantitative MS-PCR in cell lines were consistent with those of MS-PCR, and as low as 1: 10(-5) of ID4 methylation positive cells could be detected by the new methylation detection assay. In newly diagnosed acute leukemia patients, the positive rate of quantitative MSP was higher. It is concluded that a complete quantitative MSP system for ID4 methylation detection has been established and this quantitative MSP method has good specificity and high sensitivity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24762990     DOI: 10.7534/j.issn.1009-2137.2014.02.002

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  4 in total

1.  Hypomethylation of DNA-binding inhibitor 4 serves as a potential biomarker in distinguishing acquired tamoxifen-refractory breast cancer.

Authors:  Yonghui Zhang; Bin Zhang; Jing Fang; Xuchen Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  DNA methylation and leukemia susceptibility in China: Evidence from an updated meta-analysis.

Authors:  Danjie Jiang; Yirun Li; Qingxiao Hong; Yusheng Shen; Chunjing Xu; Yan Xu; Huangkai Zhu; Dongjun Dai; Guifang Ouyang; Shiwei Duan
Journal:  Mol Clin Oncol       Date:  2016-07-12

3.  Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia.

Authors:  Mian-Yang Li; Yuan-Yuan Xu; Hui-Yuan Kang; Xin-Rong Wang; Li Gao; Jian Cen; Wei Wang; Nan Wang; Yong-Hui Li; Li-Li Wang; Li Yu
Journal:  Chin Med J (Engl)       Date:  2015-08-05       Impact factor: 2.628

4.  Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma.

Authors:  Rui Xu; Qiuyan Xu; Guanglei Huang; Xinhai Yin; Jianguo Zhu; Yikun Peng; Jukun Song
Journal:  Biomed Res Int       Date:  2019-12-28       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.